Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 4/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.44 |
| ▸ | SRC | P12931 | 2/20 | 0.41 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.41 |
| ▸ | CES2 | O00748 | 2/20 | 0.40 |
| ▸ | CES1 | P23141 | 2/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10451600 | 1.00 | LMNA (0.44) | LMNAMAPK1SRCCYP2D6CES2 | |
| SCHEMBL8582794 | 1.00 | LMNA (0.44) | LMNAMAPK1SRCCYP2D6CES2 | |
| SCHEMBL6421419 | 0.98 | LMNA (0.46) | LMNAMAPK1SRCCYP2D6CES2 | |
| SCHEMBL21723253 | 0.98 | LMNA (0.46) | LMNAMAPK1SRCCYP2D6CES2 | |
| SCHEMBL15941285 | 0.98 | LMNA (0.46) | LMNAMAPK1SRCCYP2D6CES2 | |
| Benzene SCHEMBL23120173 | 0.98 | LMNA (0.46) | LMNAMAPK1SRCCYP2D6CES2 | |
| SCHEMBL9036 | 0.98 | LMNA (0.46) | LMNAMAPK1SRCCYP2D6CES2 | |
| SCHEMBL22470066 | 0.95 | LMNA (0.44) | LMNAMAPK1SRCCYP2D6CES2 | |
| Hydrochloric Acid SCHEMBL22230828 | 0.95 | LMNA (0.44) | LMNAMAPK1SRCCYP2D6CES2 | |
| SCHEMBL20723592 | 0.95 | LMNA (0.44) | LMNAMAPK1SRCCYP2D6CES2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 73 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1797190-A1 | METHOD FOR EXTRACTING FULVIC ACID MOLECULES | Bioz Agri Products Inc. (CA) | 2007-06-20 | — | — | EP | claimed |
| WO-2006000073-A1 | METHOD FOR EXTRACTING FULVIC ACID MOLECULES | BIOZ AGRI PRODUCTS INC. (CA) | 2006-01-05 | — | — | WO | claimed |
| EP-0403172-A2 | Purified enzyme and process therefor | OKLAHOMA STATE UNIVERSITY (US) | 1990-12-19 | — | — | EP | claimed |
| EP-4281108-A1 | PROCESS FOR BIOCONJUGATE PRODUCTION | Janssen Pharmaceuticals, Inc. (US) | 2023-11-29 | — | — | EP | disclosed |
| US-11639937-B2 | Fluorescent methods and materials for directed biomarker signal amplification | SIRIGEN II LIMITED (GB) | 2023-05-02 | — | — | US | disclosed |
| EP-4168417-A1 | HETEROCYCLIC COMPOUND AND AN ORGANIC ELECTROLUMINESCENCE DEVICE COMPRISING THE HETEROCYCLIC COMPOUND | Idemitsu Kosan Co., Ltd (JP) | 2023-04-26 | — | — | EP | disclosed |
| EP-4167930-A1 | METHOD FOR PRODUCING PERSONALIZED COSMETICS | BASF SE (DE) | 2023-04-26 | — | — | EP | disclosed |
| US-11209438-B2 | Fluorescent methods and materials for directed biomarker signal amplification | BECTON, DICKINSON AND COMPANY (US) | 2021-12-28 | — | — | US | disclosed |
| WO-2021255160-A1 | METHOD FOR PRODUCING PERSONALIZED COSMETICS | BASF SE (DE) | 2021-12-23 | — | — | WO | disclosed |
| WO-2021255698-A1 | HETEROCYCLIC COMPOUND AND AN ORGANIC ELECTROLUMINESCENCE DEVICE COMPRISING THE HETEROCYCLIC COMPOUND | IDEMITSU KOSAN CO., LTD. (JP) | 2021-12-23 | — | — | WO | disclosed |
| US-10859578-B2 | Fluorescent methods and materials for directed biomarker signal amplification | SKIGEN, INC. (US) | 2020-12-08 | — | — | US | disclosed |
| EP-0370958-A2 | Heparinase-producing microorganism belonging to the genus Bacillus, new heparinase and process for producing same | RESEARCH DEVELOPMENT CORPORATION OF JAPAN (JP) | 1990-05-30 | — | — | EP | disclosed |
| EP-0333033-A1 | Glutamine synthesis gene and glutamine synthetase | MEIJI SEIKA KAISHA LTD. (JP) | 1989-09-20 | — | — | EP | disclosed |
| EP-0333349-A2 | Phenethanolamine and growth hormone combinations | ELI LILLY AND COMPANY (US) | 1989-09-20 | — | — | EP | disclosed |
| EP-0298948-A2 | Process for purifying phosphoric acid | FMC Corporation (US) | 1989-01-11 | — | — | EP | disclosed |
| EP-0284105-A2 | Human manganese superoxide dismutase and methods of treatment | BIO-TECHNOLOGY GENERAL CORPORATION (US) | 1988-09-28 | — | — | EP | disclosed |
| EP-0282308-A2 | Immobilized immunoglobulin-binding proteins | REPLIGEN CORPORATION (US) | 1988-09-14 | — | — | EP | disclosed |
| EP-0246573-A2 | Pharmaceutical composition containing a 8-chlorobenzothiazepine compound and its use | TANABE SEIYAKU CO., LTD. (JP) | 1987-11-25 | — | — | EP | disclosed |
| EP-0231537-A2 | Antigenic proteins and vaccines containing them for prevention of coccidiosis | SOLVAY (BE) | 1987-08-12 | — | — | EP | disclosed |
| EP-0232130-A2 | Biological and analytical uses of phenalenone and benzphenalenone compounds | EASTMAN KODAK COMPANY (a New Jersey corporation) (US) | 1987-08-12 | — | — | EP | disclosed |